deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT00858104

Percutaneous Laser Ablation in Benign Thyroid Nodules.Long Term Results

Multicentric Randomized Controlled Study of Percutaneous Laser Ablation Versus Follow Up in Benign Thyroid Nodules. Long Term Results

Sponsor: Elesta S.R.L.

Conditions Thyroid Nodule
Interventions Percutaneous Laser Ablation
Updated 5 times since 2017 Last updated: May 23, 2014 Started: Nov 30, 2008 Primary completion: Mar 31, 2010 Completion: May 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00858104, this PHASE4 trial focuses on Thyroid Nodule and remains completed. Sponsored by Elesta S.R.L., it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Elesta S.R.L.
Data source: Elesta S.R.L.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations